In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Catherine Longworth

Catherine Longworth is a reporter covering commercial and R&D developments in the medtech industry. A graduate of St. George's, University of London, Catherine holds a BSc in Biomedical Science. Before joining Informa, she worked in the editorial team at Pharmaceutical Press, the publishing division of the Royal Pharmaceutical Society, where she wrote and edited for a number of pharmaceutical publications. After gaining experience in the world of scientific publishing, Catherine took the leap to study a postgraduate qualification in journalism. During the course, she carried out placements with local London newspapers, writing general news and building her portfolio by reporting on a wide range of current affairs such as the European migrant crisis, political protests and the London mayoral election. Catherine is passionate about human rights and is fascinated by the innovative nature of the medtech industry and the healthcare advances that have the greatest benefit to mankind. She lives in London and loves music, arts, travel, writing, reading and is always happy to receive recommendations for books or places to travel!

Advertisement
Set Alert for Articles By Catherine Longworth

Latest From Catherine Longworth

Roche And IBM Predict Future Of Big Data In Diabetes Care

Real world data and machine learning could play an increasingly important role in decision-making processes in diabetes care according to new research by Roche and IBM. The two companies conducted a major study to predict diabetes-related kidney disease in patients with chronic disease.

Artificial Intelligence Diabetic Care

MDx Health Names New CEO

MDx Health has named a new CEO to lead its commercial growth following a disappointing set of results in 2018.

Appointments Commercial

Medtech Money Flow: M&A And VC Deals, Feb. 11-17, 2019

This edition of Medtech Money Flow rounds up the M&A and venture financing deals, as recorded in our M&A and VC Deal Trackers, from Feb. 11 - 17, 2019.

M & A Deals

MDx Health Signs Exclusive Canadian Agreement

MDx Health has signed an exclusive distribution deal to make its liquid biopsy prostate cancer test available in Canada.

Canada Cancer

Device Week, Feb. 13, 2019 –  Femtech Draws Investment; Smith & Nephew/Nuvasive Merger Rumors Emerge

In this edition of Device Week, Medtech Insight’s Reed Miller talks to managing editor Marion Webb about the growing interest among investors in "femtech," technology that specifically addresses women's health issues that have been frequently overlooked in the past. And London-based reporter Catherine Longworth addresses the recent media reports that Smith & Nephew may make a bid for spine-device company Nuvasive.

Device Week Business Strategies

Edwards Lifesciences Buys CAS For $100M

Edwards Lifesciences has made its first acquisition since 2017, inking a $100m deal to buy monitoring technology company CAS Medical Systems.

M & A Deals
See All
Advertisement
UsernamePublicRestriction

Register